Support HAC
Student and Faculty Login
Faculty and Staff - Master’s Degree in Medical Laboratory Sciences (M.Med.Lab.Sc)
-
Prof. Ann Saada-Reisch, Director of the Master’s of Medical Laboratory Sciences (MMLSc) program
Ann Saada (Reisch) was born and grew up in Sweden to parents of Hungarian descent, immigrated to Israel and raised a family of four boys with her husband Joel Saada. She studied BSc in biology, MSc and PhD in microbiology, and post doctorate in neurobiology at the Hebrew University of Jerusalem.
Ann is a Professor Emeritus at the Faculty of Medicine, Hebrew University and Hadassah Medical Center in Jerusalem.
Her research focuses on inborn metabolic, mitochondrial diseases and the mitochondrial respiratory chain function on diabetes and neurodegenerative diseases.
Prof. Saada-Reisch in also experienced (25y) in clinical laboratory work. She managed the enzyme and metabolic laboratories at Hadassah Medical Center and directed the enzyme laboratory at Shaare Zedek Medical Center.
For additional info visit: . https://orcid.org/0000-0003-2951-0656
-
Dr.
(Ph.D.)Lecturer
-
Dr.
(Ph.D.)Lecturer
-
Dr.
(Ph.D.)Lecturer
-
Dr.
(M.D. M.Sc.)Lecturer
-
Since 2014 Quality Assurance Head Management at Clalit Health Service Laboratories
2014- 2015 Auditor at the Standard Institutions of Israel
2012- 2013 Accreditation General Manager Deputy at the Israel Laboratory Accreditation Authority (ISRAC)
2006-2012 Quality Assurance Head Management at Hadassah Hospitals ISO 15189 Accreditations Laboratories
2003-2012 Quality Assurance Management at Hadassah Hospitals Blood Banks.
2002-2012 Managing Hadassah Blood banking Laboratories -
Prof.
(Ph.D. MHM)Lecturer
-
Dr.
(Ph.D.)Lecturer
-
Prof.
(MD Ph.D.)Lecturer
-
Prof. Amos Adler
(M.D.)Teacher
Amos Adler, MD. Director, Clinical Microbiology, Tel Aviv Sourasky Medical Center and Associate Professor, Faculty of Medicine, Tel Aviv University.
My professional and research focus have been to understand and find ways in which microbiological diagnostic can assist in clinical decision making and improve patients outcome. I believe that the current state of affairs regarding healthcare infections is dissatisfactory, and that we must find ways in order to improve patient's safety. Treating extreme drug-resistant bacteria has already become a dead-end, due to lack of efficient drugs, and hence we must focus our attention on prevention. Accurate and timely identification of transmission is essential part of any intervention program.
